Announcements
Sidley Represents Valius Sciences in Financing Raising More Than US$10 Million for Future Cancer Diagnostics
April 23, 2026
Sidley represented Valius Sciences, a San Francisco-based healthcare diagnostics company focused on cancer treatment, in a Series Seed financing round that raised more than US$10 million. The round was led by 8VC and Basis Set Ventures.
More information about the transaction can be found here.
The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital) and included Daniel Wei (Emerging Companies and Venture Capital) and Laura DeMassa (M&A).
Contacts
Capabilities
Suggested News & Insights
Sidley Adds Mayan Katz to Emerging Companies and Venture Capital and Global Life Sciences Practices in New YorkJuly 8, 2026Sidley Adds Veteran ECVC Partner Taylor Stevens in San DiegoJune 23, 2026Sidley Represents Apono in Its Acquisition by 1PasswordJune 16, 2026Sidley Elects New Partnership Class of 52June 1, 2026Sidley Represents Restive Ventures in Formation of US$45 Million Restive Fund IIIMay 29, 2026Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory